Works about PRODROMAL symptoms

Results: 104
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Cross-Country Validation of the Arabic Version of the Prodromal Questionnaire–Brief (PQ‐B) in Young Adults from the General Population of the Middle East and North Africa (MENA) Region.

    Published in:
    International Journal of Mental Health & Addiction, 2024, v. 22, n. 5, p. 3262, doi. 10.1007/s11469-023-01048-4
    By:
    • Fekih-Romdhane, Feten;
    • Jahrami, Haitham;
    • Alhuwailah, Amthal;
    • Fawaz, Mirna;
    • Shuwiekh, Hanaa Ahmed Mohamed;
    • Helmy, Mai;
    • Mohammed Hassan, Ibrahim Hassan;
    • Naser, Abdallah Y.;
    • Zarrouq, Btissame;
    • Chebly, Marianne;
    • El-Frenn, Yara;
    • Yazbeck, Gabriella;
    • Salameh, Gaelle;
    • Hamdan-Mansour, Ayman;
    • Radwan, Eqbal;
    • Cherif, Wissal;
    • Obeid, Sahar;
    • Cheour, Majda;
    • Hallit, Souheil
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Clinical and brain volumetric correlates of decreased DTI-ALPS, suggestive of local glymphatic dysfunction, in iRBD.

    Published in:
    NPJ Parkinson's Disease, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41531-025-00942-z
    By:
    • Roura, Ignacio;
    • Pardo, Jèssica;
    • Martín-Barceló, Cristina;
    • Falcon, Carles;
    • Oltra, Javier;
    • Campabadal, Anna;
    • Bargalló, Nuria;
    • Serradell, Mònica;
    • Mayà, Gerard;
    • Montini, Angelica;
    • Pont-Sunyer, Claustre;
    • Gaig, Carles;
    • Buongiorno, Mariateresa;
    • Junqué, Carme;
    • Iranzo, Alex;
    • Segura, Bàrbara
    Publication type:
    Article
    40
    41
    42
    43
    44

    Identification of Factors to Predict Transition to Schizophrenia in Subjects with Ultra-high Risk for Psychosis: A Protocol for a Multicenter, Longitudinal Study of Sleep Parameters and Cytokine Levels.

    Published in:
    Clinical Psychopharmacology & Neuroscience, 2025, v. 23, n. 2, p. 266, doi. 10.9758/cpn.24.1239
    By:
    • Yuji Yamada;
    • Kazuo Mishima;
    • Takashi Ohnishi;
    • Michio Suzuki;
    • Takahiro Nemoto;
    • Masafumi Mizuno;
    • Toshifumi Kishimoto;
    • Hiroaki Tomita;
    • Motohiro Ozone;
    • Shingo Kitamura;
    • Kenji Hashimoto;
    • Kazuyuki Nakagome;
    • Tomiki Sumiyoshi
    Publication type:
    Article
    45
    46
    47
    48
    49
    50